FDA Approved: CELONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for CELONTIN (methsuximide) submitted by Parke-Davis Div of Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Absence Seizures
• Epilepsy

Drugs mentioned

• Celontin (Methsuximide)

Snippet

SUPPL AP for CELONTIN (METHSUXIMIDE)